Sinex

Active Ingredient(s): Phenylephrine
Category: Allergies, Cough & Cold



Sinex Overview

Oxymetazoline is a selective α1 adrenergic receptor agonist and α2 adrenergic receptor partial agonist. It is a topical decongestant, used in the form of oxymetazoline hydrochloride. It was developed from xylometazoline at E. Merck Darmstadt by Fruhstorfer in 1961.[1] Oxymetazoline is generally available as a nasal spray. Contents 1 Medical uses 2 Side effects and special considerations 2.1 Rebound congestion 2.2 Use in pregnancy 3 Overdose 4 Pharmacology 4.1...

Read more Sinex Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Vicks_Sinex

Recent Sinex Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Phenylephrine
  • Cream: 0.25%
  • Drops: 0.5%, 1%
  • Injection: 1%, 10mg/ml
  • Ointment: 0.25%
  • Solution: 0.125%, 0.16%, 0.25%, 0.5%, 1%, 10%, 100mg/10ml (10mg/ml), 10mg/ml (10mg/ml), 2.5%, 50mg/5ml (10mg/ml)
  • Spray: 0.25%, 0.5%, 1%
  • Spray, Metered: 0.25%, 0.5%, 1%
  • Suppository: 0.25%
  • Suspension: 7.5mg/5ml
  • Tablet: 10mg
  • Tablet, Chewable: 10mg
  • Tablet, Orally Disintegrated: 10mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Sinex: (2 results)

Sorted by National Drug Code
  • 37000-508 Sinex Oral Capsule, Liquid Filled by The Procter & Gamble Manufacturing Company
  • 37000-509 Sinex Kit by The Procter & Gamble Manufacturing Company

Other drugs which contain Phenylephrine or a similar ingredient: (188 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 24 March 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA